- Home
- WAFU vs OGEN Comparison
WAFU vs OGEN Comparison
Compare WAFU & OGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WAFU
- OGEN
- Stock Information
- Founded
- WAFU 1999
- OGEN 1996
- Country
- WAFU China
- OGEN United States
- Employees
- WAFU N/A
- OGEN N/A
- Industry
- WAFU Other Consumer Services
- OGEN Biotechnology: Pharmaceutical Preparations
- Sector
- WAFU Real Estate
- OGEN Health Care
- Exchange
- WAFU Nasdaq
- OGEN Nasdaq
- Market Cap
- WAFU 8.8M
- OGEN 4.5M
- IPO Year
- WAFU 2019
- OGEN N/A
- Fundamental
- Price
- WAFU $1.84
- OGEN $0.34
- Analyst Decision
- WAFU
- OGEN
- Analyst Count
- WAFU 0
- OGEN 0
- Target Price
- WAFU N/A
- OGEN N/A
- AVG Volume (30 Days)
- WAFU 59.4K
- OGEN 389.1K
- Earning Date
- WAFU 01-01-0001
- OGEN 11-07-2024
- Dividend Yield
- WAFU N/A
- OGEN N/A
- EPS Growth
- WAFU N/A
- OGEN N/A
- EPS
- WAFU N/A
- OGEN N/A
- Revenue
- WAFU $7,223,220.00
- OGEN $7,466.00
- Revenue This Year
- WAFU N/A
- OGEN N/A
- Revenue Next Year
- WAFU N/A
- OGEN N/A
- P/E Ratio
- WAFU N/A
- OGEN N/A
- Revenue Growth
- WAFU N/A
- OGEN N/A
- 52 Week Low
- WAFU $1.58
- OGEN $0.29
- 52 Week High
- WAFU $2.85
- OGEN $7.74
- Technical
- Relative Strength Index (RSI)
- WAFU 49.50
- OGEN 37.15
- Support Level
- WAFU $1.77
- OGEN $0.29
- Resistance Level
- WAFU $1.91
- OGEN $0.45
- Average True Range (ATR)
- WAFU 0.14
- OGEN 0.04
- MACD
- WAFU -0.02
- OGEN 0.02
- Stochastic Oscillator
- WAFU 17.19
- OGEN 28.88
About WAFU Wah Fu Education Group Limited
Wah Fu Education Group Ltd is involved in providing online exam preparation services and related technology solutions and also produces online training course materials in China. It develops online educational materials that are offered through the cloud and that can be used for a wide range of purposes, such as standard examination preparation, professional training, and interactive programs for educational purposes other than exam preparation. Its segments are Online Education Services, and Technological Development and Operation Service. The company generates maximum revenue from the Online Education Services segment.
About OGEN Oragenics Inc.
Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's lead product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification.